Stock listing

Regeneron Pharmaceuticals, Inc.

Selected listing: REGNUS · BVL · PEN · PE

Regeneron Pharmaceuticals, Inc. (BVL:REGNUS), Health Technology. Latest release Oct 6, 2026: Regeneron Showcases Advances in Care Across Several Cancers…

REGNUS:BVLPENPEUpdated September 25, 2026

Ticker: BVL:REGNUS
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BVL
Currency: PEN

Latest news from Regeneron Pharmaceuticals, Inc.

Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026

October 5, 2026

Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026

October 6, 2026

Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)

October 1, 2026

Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss

October 1, 2026

Upcoming Webinar Hosted by Xtalks: Inside Regeneron's Path to Scientific Intelligence and R&D Efficiency

October 1, 2026

All Regeneron Pharmaceuticals, Inc. news →

Events

Replays

Regeneron Pharmaceuticals, Inc. (REGN) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 08:30 AM ET
Watch
Regeneron Pharmaceuticals, Inc. (REGN) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 08:30 AM ET
Watch
Regeneron Pharmaceuticals, Inc. (REGN) Q4 2025 Earnings Call
Fri, Jan 30, 2026 · 08:30 AM ET
Watch

Research Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. company profile

View the public company page for Regeneron Pharmaceuticals, Inc. on 6ix.

Regeneron Pharmaceuticals, Inc. news

Read company news and market updates connected to Regeneron Pharmaceuticals, Inc..

Regeneron Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Regeneron Pharmaceuticals, Inc..